ПРЕПРИНТ
О результатах, изложенных в препринтах, не следует сообщать в СМИ как о проверенной информации.
Оценка связанного с асбестом риска для здоровья основана на опыте прошлого, когда содержание асбестовых волокон в воздухе на рабочих местах было выше. Волокна присутствуют в окружающей среде в результате эрозии поверхностных отложений и деятельности человека, не связанной с асбестовой промышленностью. При целенаправленном поиске асбестовые волокна нередко находят на аутопсии. Результаты многих исследований недостаточно объективны. Например, при обнаружении волокон мезотелиому или рак легкого иногда классифицируют как асбестообусловленные, хотя причинно-следственная связь остается недоказанной. Некоторые исследования полагаются на непроверенные анамнестические данные о профессиональном или бытовом контакте с асбестом. Достоверные данные можно получить в экспериментах с регистрацией средней продолжительности жизни животных. Различные типы асбеста имеют свои технические преимущества и предпочтительные области применения. Дорожное движение безопаснее при использовании асбестосодержащих тормозных накладок. Асбоцементные конструкции прочны и недороги. Огнезащитные свойства асбеста хорошо известны. Можно обоснованно предположить, что отказ от асбестосодержащих тормозных накладок, огнезащитных и изоляционных материалов приведет к увеличению ущерба от дорожно-транспортных происшествий, пожаров и вооруженных конфликтов.
Яргин С. В. 2025. Асбест и антиасбестовая кампания: медицинские и экономические аспекты. PREPRINTS.RU. https://doi.org/10.24108/preprints-3113807
1. Asgharian B, Owen TP, Kuempel ED, Jarabek AM (2018) Dosimetry of inhaled elongate mineral particles in the respiratory tract: The impact of shape factor. Toxicology and Applied Pharmacology 361: 27-35. https://doi.org/10.1016/j.taap.2018.05.001
2. Bayram M, Bakan ND (2014) Environmental exposure to asbestos: from geology to mesothelioma. Current Opinion in Pulmonary Medicine 20: 301-307. https://doi.org/10.1097/MCP.0000000000000053
3. Berman DW, Crump KS, Chatfield EJ, Davis JM, Jones AD (1995) The sizes, shapes, and mineralogy of asbestos structures that induce lung tumors or mesothelioma in AF/HAN rats following inhalation. Risk Analysis 15: 181-195. https://doi.org/10.1111/j.1539-6924.1995.tb00312.x
4. Berman DW, Crump KS (2008) A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Critical Reviews in Toxicology 38 Suppl. 1:49-73. https://doi.org/10.1080/10408440802273156
5. Bernstein DM (2014) The health risk of chrysotile asbestos. Current Opinion in Pulmonary Medicine 20:366-370. https://doi.org/10.1097/MCP.0000000000000064
6. Bernstein DM, Toth B, Rogers RA, Kling DE, Kunzendorf P, Phillips JI, Ernst H (2020) Evaluation of the dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to TiO2, chrysotile, crocidolite or amosite asbestos in a 90-day quantitative inhalation toxicology study - Interim results Part 2: Histopathological examination, Confocal microscopy and collagen quantification of the lung and pleural cavity. Toxicology and Applied Pharmacology 387: 114847. https://doi.org/10.1016/j.taap.2019.114847
7. Berry TA, Belluso E, Vigliaturo R, Gieré R, Emmett EA, Testa JR, Steinhorn G, Wallis SL (2022) Asbestos and other hazardous fibrous minerals: potential exposure pathways and associated health risks. International Journal of Environmental Research and Public Health 19(7): 4031. https://doi.org/10.3390/ijerph19074031
8. Bibby AC, Tsim S, Kanellakis N, Ball H, Talbot DC, Blyth KG, Maskell NA, Psallidas I (2016) Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. European Respiratory Review 25:472-86. https://doi.org/10.1183/16000617.0063-2016
9. Brims FJ (2009) Asbestos - a legacy and a persistent problem. Journal of the Royal Naval Medical Service 95(1): 4-11. PMID: 19425525
10. Carbone M, Yang H (2017) Mesothelioma: recent highlights. Annals of Translational Medicine 5(11): 238. https://doi.org/10.21037/atm.2017.04.29
11. Carbone M, Adusumilli PS, Alexander HR Jr, Baas P, Bardelli F, Bononi A, Bueno R, Felley-Bosco E, Galateau-Salle F, Jablons D, Mansfield AS, Minaai M, de Perrot M, Pesavento P, Rusch V, Severson DT, Taioli E, Tsao A, Woodard G, Yang H, Zauderer MG, Pass HI (2019) Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA: a Cancer Journal For Clinicians 69(5):402-429. https://doi.org/10.3322/caac.21572
12. Carbone M, Gazdar A, Butel JS (2020) SV40 and human mesothelioma. Translational Lung Cancer Research 9(Suppl 1): S47-S59. https://doi.org/10.21037/tlcr.2020.02.03.
13. Casali M, Carugno M, Cattaneo A, Consonni D, Mensi C, Cavallo DM, Somigliana A, Pesatori AC (2015) Asbestos lung burden in necroscopic samples from the general population of Milan, Italy. Annals of Occupational Hygiene 59: 909-21. https://doi.org/10.1093/annhyg/mev028
14. Cersosimo F, Barbarino M, Lonardi S, Vermi W, Giordano A, Bellan C, Giurisato E (2021) Mesothelioma malignancy and the microenvironment: molecular mechanisms. Cancers (Basel) 13(22): 5664. https://doi.org/10.3390/cancers13225664
15. Chen Z, Gaudino G, Pass HI, Carbone M, Yang H (2017) Diagnostic and prognostic biomarkers for malignant mesothelioma: an update. Translational Lung Cancer Research 6:259-69. https://doi.org/10.21037/tlcr.2017.05.06
16. Cicala C, Pompetti F, Carbone M (1993) SV40 induces mesotheliomas in hamsters. American Journal of Pathology 142: 1524-33. PMID: 8388174
17. Coin PG, Roggli VL, Brody AR (1994) Persistence of long, thin chrysotile asbestos fibers in the lungs of rats. Environ Health Perspective 102:197-9. https://doi.org/10.1289/ehp.94102s5197
18. Creaney J, Dick IM, Robinson BW (2015) Discovery of new biomarkers for malignant mesothelioma. Curr Pulmonology Reports 4: 15-21. https://doi.org/10.1007/s13665-015-0106-8
19. Currie GP, Watt SJ, Maskell NA (2009) An overview of how asbestos exposure affects the lung. BMJ 339: b3209. https://doi.org/10.1136/bmj.b3209
20. Davis JM, Beckett ST, Bolton RE, Collings P, Middleton AP (1978) Mass and number of fibres in the pathogenesis of asbestos-related lung disease in rats. British Journal of Cancer 37:673-88. https://doi.org/10.1038/bjc.1978.105
21. Dipper A, Maskell N, Bibby A (2021) Ancillary diagnostic investigations in malignant pleural mesothelioma. Cancers (Basel) 13(13): 3291. https://doi.org/10.3390/cancers13133291
22. Dodson RF, Williams MG Jr, Corn CJ, Brollo A, Bianchi C (1990) Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. American Review of Respiratory Diseases 142:843-7. https://doi.org/10.1164/ajrccm/142.4.843
23. Donaldson K, Poland CA, Murphy FA, MacFarlane M, Chernova T, Schinwald A (2013) Pulmonary toxicity of carbon nanotubes and asbestos - similarities and differences. Advanced Drug Delivery Reviews 65: 2078-86. https://doi.org/10.1016/j.addr.2013.07.014
24. Elovskaia LT (1997) Antiasbestovaja kampanija i konferencija po probleme “Asbest i zdorov'e” [Anti-asbestos campaign and conference on “Asbestos and health issues”]. Meditsina Truda i Promyshlennaia Ekologiia [Russian journal of occupational health and industrial ecology] (9): 16-21. PMID: 9440939
25. Feder IS, Tischoff I, Theile A, Schmitz I, Merget R, Tannapfel A. The asbestos fibre burden in human lungs: new insights into the chrysotile debate. Eur Respir J. 2017;49(6):1602534. doi: 10.1183/13993003.02534-2016
26. Fedoseev A.D. Федосеев А.Д., Григорьева Л.Ф., Макарова Т.А. Волокнистые силикаты. Природные и синтетические асбесты. Москва: Наука, 1966 - 184 с.
27. Ferrari L, Carugno M, Mensi C, Pesatori AC (2020) Circulating epigenetic biomarkers in malignant pleural mesothelioma: state of the art and critical evaluation. Frontiers of Oncology 10: 445. https://doi.org/10.3389/fonc.2020.00445
28. Finkelstein MM. Letter to the Editor re Bernstein et al: Health risk of chrysotile revisited. Crit Rev Toxicol, 2013;43(2):154-183. Crit Rev Toxicol 2013;43(8):707-708
29. Finkelstein MM, Meisenkothen C (2010) Malignant mesothelioma among employees of a Connecticut factory that manufactured friction materials using chrysotile asbestos. Annals of Occupational Hygiene 54(6): 692-6. https://doi.org/10.1093/annhyg/meq046
30. Frank AL (2020) Global use of asbestos - legitimate and illegitimate issues. J Occupational Medicine and Toxicology 15:16. https://doi.org/10.1186/s12995-020-00267-y
31. Gaudino G, Xue J, Yang H (2020) How asbestos and other fibers cause mesothelioma. Translational Lung Cancer Research 9(Suppl 1): S39-46. https://doi.org/10.21037/tlcr.2020.02.01
32. Gibbs AR, Stephens M, Griffiths DM, Blight BJ, Pooley FD (1991) Fibre distribution in the lungs and pleura of subjects with asbestos related diffuse pleural fibrosis. British Journal of Industrial Medicine 48: 762-70. https://doi.org/10.1136/oem.48.11.762
33. Goldberg M, Imbernon E, Rolland P, Gilg Soit Ilg A, Savès M, de Quillacq A, Frenay C, Chamming's S, Arveux P, Boutin C, Launoy G, Pairon JC, Astoul P, Galateau-Sallé F, Brochard P (2006) The French national mesothelioma surveillance program. Occupational and Environmental Medicine 63: 390-5. https://doi.org/10.1136/oem.2005.023200
34. Goodman JE, Rhomberg LR, Cohen SM, Mundt KA, Case B, Burstyn I, Becich MJ, Gibbs G (2025) Challenges in defining thresholds for health effects: some considerations for asbestos and silica. Front Epidemiol 5: 1557023. doi: 10.3389/fepid.2025.1557023
35. Greim H, Utell MJ, Maxim LD, Niebo R (2014) Perspectives on refractory ceramic fiber (RCF) carcinogenicity: comparisons with other fibers. Inhalation Toxicology 26: 789-810. https://doi.org/10.3109/08958378.2014.953276
36. Grigoriu BD, Grigoriu C, Chahine B, Gey T, Scherpereel A (2009) Clinical utility of diagnostic markers for malignant pleural mesothelioma. Monaldi Archive of Chest Diseases 71(1): 31-38. https://doi.org/10.4081/monaldi.2009.374
37. Gualtieri AF (2023) Journey to the centre of the lung. The perspective of a mineralogist on the carcinogenic effects of mineral fibres in the lungs. Journal of Hazardous Materials 442: 130077. https://doi.org/10.1016/j.jhazmat.2022.130077
38. Gupta SS, Singh KP, Gupta S, Dusinska M, Rahman Q (2022) Do carbon nanotubes and asbestos fibers exhibit common toxicity mechanisms? Nanomaterials (Basel) 12(10): 1708. https://doi.org/10.3390/nano12101708
39. Gwinn MR, DeVoney D, Jarabek AM, Sonawane B, Wheeler J, Weissman DN, Masten S, Thompson C (2011) Meeting report: mode(s) of action of asbestos and related mineral fibers. Environmental Health Perspectives 119: 1806-10. https://doi.org/10.1289/ehp.1003240
40. Harington JS (1991) The carcinogenicity of chrysotile asbestos. Annals of the New York Academy of Sciences 643:465-72. https://doi.org/10.1111/j.1749-6632.1991.tb24496.x
41. Harris EJA, Musk A, de Klerk N, Reid A, Franklin P, Brims FJH (2019) Diagnosis of asbestos-related lung diseases. Expert Rev Respiratory Medicine 13(3):241-9. https://doi.org/10.1080/17476348.2019.1568875
42. Hesterberg TW, Barrett JC (1984) Dependence of asbestos- and mineral dust-induced transformation of mammalian cells in culture on fiber dimension. Cancer Research 44:2170-80. PMID: 6324999
43. Hillerdal G, Henderson DW (1997) Asbestos, asbestosis, pleural plaques and lung cancer. Scand Journal of Work and Environmental Health 23(2): 93-103. https://doi.org/10.5271/sjweh.186
44. Ho M, Bera TK, Willingham MC, Onda M, Hassan R, FitzGerald D, Pastan I (2007) Mesothelin expression in human lung cancer. Clinical Cancer Research 13(5):1571-5. https://doi.org/10.1158/1078-0432.CCR-06-2161
45. Hodgson JT, Darnton A (2000) The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Annals of Occupational Hygiene 44:565-601. PMID: 11108782
46. Hodgson JT, Darnton A (2010) Mesothelioma risk from chrysotile. Occupational and Environmental Medicine 67: 432. https://doi.org/10.1136/oem.2009.052860
47. IARC (1996) Consensus report. Mechanisms of fibre carcinogenesis. IARC Scientific Publications (140): 1-9. PMID: 9221250
48. Iatsenko AS, Kogan FM (1990) Professional'naja zabolevaemost' i smertnost' ot zlokachestvennyh novoobrazovanij sredi lic, imejushhih professional'nyi kontakt s asbestovoi pyl'ju [Occupational morbidity and mortality in malignant neoplasms among persons professionally exposed to asbestos dust]. Gigiena Truda i Professional’nye Zabolevaniia [Work hygiene and professional diseases] (2): 10-2. PMID: 2139623
49. Iatsenko AS, Kogan FM, El'nichnykh LN, Remizova II (1991) Sravnitrlnoe issledivanie fibrinigennoi aktivnosti pyly pri proizvodstve asbestoformovannyh detalei [Comparative evaluation of the dust's fibrinogen activity in asbestos-forming units production]. Gigiena i Sanitariia [Hygiene and sanitation] (8):27-9. PMID: 1937092
50. Iatsenko AS, Kogan FM, Fomina AS, Zykova VA, Nikitina OV, Vanchugova NN, Bogdanov GB, Aliamovskiĭ SI, Pereliaeva LA (1994) O vzaimosvyazi mezhdu biologicheskoy agressivnostiu i nekotorymi fiziko-khimicheskimi svoystvami promyshlennoy pyli, voznikayushchey pri proizvodstve i primenenii friktsionnykh izdelii [Correlation between biologic aggression and some physical and chemical properties of industrial dust caused by use of friction tools]. Meditsina Truda i Promyshlennaia Ekologiia [Russian journal of occupational health and industrial ecology] (12): 29-33. PMID: 7719655
51. Ilgren E, Van Orden DR, Lee RJ, Kamiya YM, Hoskins JA (2015) Further studies of Bolivian crocidolite - Part IV: Fibre width, fibre drift and their relation to mesothelioma induction: Preliminary findings. Epidemiology Biostatistics and Public Health 12: e11167-1. https://doi.org/10.2427/11167
52. Izmerov NF, Kovalevskii EV (2004) Normativnoe obespechenie kontroliruemogo ispol'zovanija asbestsoderzhashhih materialov v stroitel'stve [Regulations of controlled use of asbestos-containing materials in construction industry]. Meditsina Truda i Promyshlennaia Ekologiia [Russian journal of occupational health and industrial ecology] (5): 5-12. PMID: 15216638
53. Izmerov NF, Elovskaia LT, Milishnikova VV, Burmistrova TB, Kovalevskii EV (1998) Khrizotil-asbest v Rossii: nekotoryye rezulʹtaty i perspektivnyye napravleniya issledovaniy [Chrysotile asbestos in Russia: certain results and promising research directions]. Meditsina Truda i Promyshlennaia Ekologiia [Russian journal of occupational health and industrial ecology] (10): 1-7. PMID: 9855738
54. Janosikova M, Nakladalova M, Stepanek L. Current causes of mesothelioma: how has the asbestos ban changed the perspective? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023;167(2):99-108. doi: 10.5507/bp.2023.008
55. Jargin SV (2017) Asbestos, mesothelioma and lung cancer: a comment. Galore International Journal of Health Sciences and Research; 2(4):19-29. https://www.gijhsr.com/GIJHSR_Vol.2_Issue.4_Dec2017/4.pdf
56. Jargin SV (2018) Asbestos and mesothelioma: a comment. Indian Journal of Occupational and Environmental Medicine 22(2):113-4. https://doi.org/10.4103/ijoem.IJOEM_49_18
57. Järvholm B, Burdorf A. Asbestos and disease - a public health success story? Scand J Work Environ Health. 2024;50(2):53-60. doi: 10.5271/sjweh.4146
58. Jasani B, Gibbs A (2012) Mesothelioma not associated with asbestos exposure. Archives of Pathology and Laboratory Medicine 136: 262-7. https://doi.org/10.5858/arpa.2011-0039-RA
59. Kane AB, Hurt RH, Gao H (2018) The asbestos-carbon nanotube analogy: An update. Toxicology and Applied Pharmacology 361:68-80. https://doi.org/10.1016/j.taap.2018.06.027
60. Kaptsov VA, Kashanskii SV, Domnin SG, Tikhova TS, Trofimova EV, Novoselova TA, Bogdanov GB. (2003) Zheleznodorozhnoye ispolʹzovaniye asbestosoderzhashchego shchebnya: ekologo-gigiyenicheskiye aspekty [Railway use of asbestos-containing rubble: environmental hygienic aspects]. Gigiena i Sanitariia [Hygiene and sanitation] (5):11-5. PMID: 14598741
61. Kashanskii SV (2008) Mezotelioma v rossii: sistemnyj obzor 3576 opublikovannyh sluchaev s pozicij mediciny truda [Mesothelioma in Russia: systematic review of 3576 published cases from occupational medicine viewpoint]. Meditsina Truda i Promyshlennaia Ekologiia [Russian journal of occupational health and industrial ecology] (3): 15-21. PMID: 18461798
62. Kashanskii SV, Kogan FM (1995) Opasnostʹ razvitiya raka legkikh pri proizvodstve asbestovykh paneley [The danger of developing lung cancer in the manufacture of asbestos panel]. Meditsina Truda i Promyshlennaia Ekologiia [Russian journal of occupational health and industrial ecology] (5): 19-22. PMID: 7663849
63. Kashanskii SV, Kogan FM, Malysheva LG, Zykova VA (1994) Sravnitelʹnaya otsenka fibrogeneza i toksichnosti asbestosoderzhashchikh teplozashchitnykh materialov [Comparative evaluation of fibrogenesis and toxicity of asbestos-containing heat-proof materials]. Meditsina Truda i Promyshlennaia Ekologiia [Russian journal of occupational health and industrial ecology] (1): 17-21. PMID: 7804707
64. Kashanskii SV, Domnin SG, Plotko EG, Kuz'min SV, Seliankina SV, Likhacheva EI (2004) Sovremennye problemy asbesta i perspektivnye napravlenija issledovanii [Contemporary problems of asbestos and prospective research directions]. Meditsina Truda i Promyshlennaia Ekologiia [Russian journal of occupational health and industrial ecology] (9): 16-9. PMID: 15568563
65. Kashanskii SV, Zhetpisbaev BA, Il'derbaev OZ, Ermenbai OT (2008) Mezotelioma v Respublike Kazakhstan: obzor [Mesothelioma in the Republic of Kazakhstan: a review]. Gigiena i Sanitariia [Hygiene and sanitation] (5):13-7. PMID: 14598741
66. Kazantsev V.A. The use of bronchological sanation for treatment of community-acquired pneumonia. Russian Respiratory Society. 14th National Congress of Lung diseases: proc. congr., Moscow, 2004 June 22–26. M., 2004. P. 361. [In Russian].
67. Kerger BD, James RC, Galbraith DA (2014) Tumors that mimic asbestos-related mesothelioma: Time to consider a genetics-based tumor registry? Frontiers in Genetics 5:151. https://doi.org/10.3389/fgene.2014.00151
68. Kogan FM (1995) Sovremennye predstavlenija o bezopasnosti asbesta [Modern concept of asbestos safety]. Argo, Ekaterinburg. (in Russian)
69. Kogan FM. Основные результаты исследований по проблеме «Асбест-Здоровье». В кн.: Кашанский С.В. и др., ред. Профилактика асбестообусловленных заболеваний: Сб. публ. Асбест: Асбестовая ассоц. 2002a; 7-9.
70. Kogan FM. К вопросу о нормировании асбестсодержащих пылей в воздухе рабочих помещений. В кн.: Кашанский С.В. и др., ред. Профилактика асбестообусловленных заболеваний: Сб. публ. Асбест: Асбестовая ассоц. 2002b; 57-63.
71. Kogan FM, Kashanskii SV, Plotko EG, Berzin SA, Bogdanov GB (1993) Vliyaniye nizkoy kontsentratsii asbestosoderzhashchey pyli [Effect of low concentration of asbestos-containing dust]. Meditsina Truda i Promyshlennaia Ekologiia [Russian journal of occupational health and industrial ecology] (5-6): 6-10. PMID: 8069511
72. Kohyama N, Suzuki Y (1991) Analysis of asbestos fibers in lung parenchyma, pleural plaques, and mesothelioma tissues of North American insulation workers. Annals of the New York Academy of Sciences 643: 27-52. https://doi.org/10.1111/j.1749-6632.1991.tb24442.x
73. Koigeldinova Sh.S., Ibraev S.A., Zhuzbaeva G.O., Kasymova A.K. Modern view on the problem occupational lung disease exposure chrysotile asbestos. Bulletin of the Karaganda University. Series Biology. Medicine. Geography 2015;79(3):122-131.
74. Kovalevskii EV (2009) Gigienicheskaja ocenka ispol'zovanija asbestsoderzhashhih frikcionnyh izdelii [Hygienic evaluation of asbestos-containing friction goods application]. Meditsina Truda i Promyshlennaia Ekologiia [Russian journal of occupational health and industrial ecology] (7): 1-6. PMID: 19718834
75. Krasovskii GN, Egorova NA (1985) Asbest i kachestvo pitʹyevoy vody [Asbestos and the quality of drinking water]. Gigiena i Sanitariia [Hygiene and sanitation] (3):64-7. PMID: 3891523
76. Krasovskii GN, Mozhaev EA (1993) Asbest v pitʹyevoy vode (obzor) [Asbestos in drinking water (review)]. Gigiena i Sanitariia [Hygiene and sanitation] (6):20-22. PMID: 8406075
77. Kraus T, Jonigk D. Mesotheliome – 30 Jahre nach dem Asbestverbot in Deutschland. Pathologie (Heidelb). 2024;45(5):305-308. doi: 10.1007/s00292-024-01350-5.
78. Kwak K, Kang D, Paek D (2022) Environmental exposure to asbestos and the risk of lung cancer: a systematic review and meta-analysis. Occupational and Environmentall Medicine 79(3):207-14. https://doi.org/10.1136/oemed-2020-107222
79. Landrigan PJ, Nicholson WJ, Suzuki Y, Ladou J (1999) The hazards of chrysotile asbestos: a critical review. Industrial Health 37:271-80. https://doi.org/10.2486/indhealth.37.271
80. Langer AM, Nolan RP (1994) Chrysotile: its occurrence and properties as variables controlling biological effects. Annals of Occupational Hygiene 38(4): 427-51. https://doi.org/10.1093/annhyg/38.4.427
81. Larsen G (1989) Experimental data on in vitro fibre solubility. IARC Scientific Publications (90): 134-9. PMID: 2545602
82. Lenters V, Vermeulen R, Dogger S, Stayner L, Portengen L, Burdorf A, Heederik D (2011) A meta-analysis of asbestos and lung cancer: is better quality exposure assessment associated with steeper slopes of the exposure-response relationships? Environmental Health Perspectives 119(11): 1547-55. https://doi.org/10.1289/ehp.1002879
83. Likhacheva EI, Iarina AL, Vagina ER, Klimina MS, Obukhova TIu, Dovgoliuk TA, Kashanskiĭ SV (2000) Klinicheskie osobennosti zabolevanij legkih ot vozdejstvija pyli hrizotil-asbesta [Clinical features of pulmonary diseases caused by chrysotile asbestos dust]. Meditsina Truda i Promyshlennaia Ekologiia [Russian journal of occupational health and industrial ecology] (11): 30-3. PMID: 11280281
84. Lindholm PM, Salmenkivi K, Vauhkonen H, Nicholson AG, Anttila S, Kinnula VL, Knuutila S (2007) Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH. Cytogenetic and Genome Research 119: 46-52. https://doi.org/10.1159/000109618
85. Lorenzini E, Ciarrocchi A, Torricelli F (2021) Molecular fingerprints of malignant pleural mesothelioma: not just a matter of genetic alterations. Journal of Clinical Medicine 10(11): 2470. https://doi.org/10.3390/jcm10112470
86. Malinconico S, Paglietti F, Serranti S, Bonifazi G, Lonigro I (2022) Asbestos in soil and water: A review of analytical techniques and methods. Journal of Hazardous Materials 436: 129083. https://doi.org/10.1016/j.jhazmat.2022.129083
87. Marsili D, Terracini B, Santana VS, Ramos-Bonilla JP, Pasetto R, Mazzeo A, Loomis D, Comba P, Algranti E (2016) Prevention of asbestos-related disease in countries currently using asbestos. International Journal of Environmental Research and Public Health 13(5): 494. https://doi.org/10.3390/ijerph13050494
88. Mazzoni E., Bononi I., Rotondo J.C., Mazziotta C., Libener R., Guaschino R., Gafà R., Lanza G., Martini F., Tognon M. Sera from patients with malignant pleural mesothelioma tested positive for IgG antibodies against SV40 large t antigen: the viral oncoprotein. J. Oncol. 2022;2022:7249912. doi: 10.1155/2022/7249912
89. Milishnikova VV, Loshchilov IU, Gladkova EV, Aksenova AO, Turkina LA (1990) Endoskopicheskaya i morfologicheskaya kharakteristika bronkhov i legkikh pri asbestoze i pylevom bronkhite u rabotnikov asbotekstilʹnoy promyshlennosti [Endoscopic and morphological characteristics of the bronchi and lungs in asbestosis and dust-induced bronchitis in asbestos-textile industry workers]. Gigiena Truda i Professional’nye Zabolevaniia [Work hygiene and professional diseases] (7): 19-22. PMID: 2210423
90. Mossman BT, Lippmann M, Hesterberg TW, Kelsey KT, Barchowsky A, Bonner JC (2011) Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. Journal of Toxicology and Environmental Health. Part B, Critical Reviews 14(1-4): 76-121. https://doi.org/10.1080/10937404.2011.556047
91. Musti M, Kettunen E, Dragonieri S, Lindholm P, Cavone D, Serio G, Knuutila S (2006) Cytogenetic and molecular genetic changes in malignant mesothelioma. Cancer Genetics and Cytogenetics 170: 9-15. https://doi.org/10.1016/j.cancergencyto.2006.04.011
92. Nash A, Creaney J. Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths. Curr Oncol Rep. 2023;25(12):1515-1522. doi: 10.1007/s11912-023-01479-1.
93. Neiman SM, Vezentsev AI, Kashanskii SV (2006) O bezopasnosti asbestocementnyh materialov i izdelii [About safety of asbestos-cement materials and products]. Stroimaterialy, Moscow. (in Russian)
94. Nel A. Carbon nanotube pathogenicity conforms to a unified theory for mesothelioma causation by elongate materials and fibers. Environ Res. 2023;230:114580. doi: 10.1016/j.envres.2022.114580
95. Nel AE, Pavlisko EN, Roggli VL. The Interplay Between the Immune System, Tumor Suppressor Genes, and Immune Senescence in Mesothelioma Development and Response to Immunotherapy. J Thorac Oncol. 2024 Apr;19(4):551-564. doi: 10.1016/j.jtho.2023.11.017.
96. Nicholson WJ (1991) Comparative dose-response relationships of asbestos fiber types: magnitudes and uncertainties. Annals of the New York Academy of Sciences 643: 74-84. https://doi.org/10.1111/j.1749-6632.1991.tb24446.x
97. Noonan CW (2017) Environmental asbestos exposure and risk of mesothelioma. Annals of Translational Medicine 5(11): 234. https://doi.org/10.21037/atm.2017.03.74
98. Panou V, Vyberg M, Weinreich UM, Meristoudis C, Falkmer UG, Røe OD (2015) The established and future biomarkers of malignant pleural mesothelioma. Cancer Treatment Reviews 41: 486-95. https://doi.org/10.1016/j.ctrv.2015.05.001
99. Pantazopoulos I, Boura P, Xanthos T, Syrigos K (2013) Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma. European Respiratory Journal 41(3): 706-15. https://doi.org/10.1183/09031936.00226111
100. Paustenbach D, Brew D, Ligas S, Heywood J (2021) A critical review of the 2020 EPA risk assessment for chrysotile and its many shortcomings. Critical Reviews in Toxicology 51(6): 509-539. https://doi.org/10.1080/10408444.2021.1968337
101. Peña-Castro M, Montero-Acosta M, Saba M. A critical review of asbestos concentrations in water and air, according to exposure sources. Heliyon. 2023;9(5):e15730. doi: 10.1016/j.heliyon.2023.e15730
102. Pezerat H (2009) Chrysotile biopersistence: the misuse of biased studies. International Journal of Occupational and Environmental Health 15:102-106. https://doi.org/10.1179/107735209799449770
103. Pylev LN (1987) Rolʹ modifitsiruyushchikh faktorov v kantserogennom deystvii asbesta i asbestosoderzhashchikh pyley [The role of modifying factors in the carcinogenic effect of asbestos and asbestos-containing dusts]. Ekspimentalnaia Onkologiia [Experimental oncology] 9(5): 14-7. PMID: 3319515
104. Pylev LN, Kogan FM, Kulagina TF (1988) Kantserogennaya aktivnostʹ asbestotsementnoy pyli [Carcinogenic activity of asbestos cement dust]. Gigiena Truda i Professional’nye Zabolevaniia [Work hygiene and professional diseases] (7): 55-7. PMID: 3181789
105. Pylev LN, Smirnova OV, Vasil'eva LA, Khrustalev SA, Vezentsev AI, Gudkova EA, Naumova LN (2010) Eksperimental'noe obosnovanie kancerogennoj opasnosti asbestocementnoi promyshlennosti i ee produkcii [Experimental rationale for carcinogenic risk of asbestos cement industry and its products]. Gigiena i Sanitariia [Hygiene and sanitation] (6): 61-5. PMID: 21381365
106. Pylev L.N., Smirnova O.V., Vezentsev A.I. Chrysotile-cement industry - is it a source of carcinogenic hazard to humans? Toksikologicheskiy vestnik = Toxicological Review” 2011;94):46-50.
107. Ramada Rodilla JM, Calvo Cerrada B, Serra Pujadas C, Delclos GL, Benavides FG (2022) Fiber burden and asbestos-related diseases: an umbrella review. Gaceta Sanitaria 36(2):173-83. https://doi.org/10.1016/j.gaceta.2021.04.001
108. Repina ZhV, Chemyakina NA, Tarskaya-Lapteva EG (2009) Khrizotiltsementnyye stroitelʹnyye materialy. Oblasti ispolʹzovaniya [Chrysotile cement building materials. Areas of use]. Yekaterinburg, AMB. (in Russian)
109. Røe OD, Stella GM (2015) Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic. European Respiratory Review 24: 115-31. https://doi.org/10.1183/09059180.00007014
110. Røe OD, Anderssen E, Helge E, Pettersen CH, Olsen KS, Sandeck H, Haaverstad R, Lundgren S, Larsson E (2009) Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype. PLoS One.;4: e6554. https://doi.org/10.1371/journal.pone.0006554
111. Rossi G, Davoli F, Poletti V, Cavazza A, Lococo F (2021) When the diagnosis of mesothelioma challenges textbooks and guidelines. Journal of Clinical Medicine 10(11): 2434. https://doi.org/10.3390/jcm10112434
112. Rossini M, Rizzo P, Bononi I, Clementz A, Ferrari R, Martini F, Tognon MG (2018) New perspectives on diagnosis and therapy of malignant pleural mesothelioma. Frontiers of Oncology 8: 91. https://doi.org/10.3389/fonc.2018.00091
113. Schillebeeckx E, van Meerbeeck JP, Lamote K (2021) Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis. European Respiratory Review 30(162): 210057. https://doi.org/10.1183/16000617.0057-2021
114. Sebastien P, Janson X, Gaudichet A, Hirsch A, Bignon J (1980) Asbestos retention in human respiratory tissues: comparative measurements in lung parenchyma and in parietal pleura. IARC Scientific Publications (30): 237-46. PMID: 7239642
115. Sekido Y (2013) Molecular pathogenesis of malignant mesothelioma. Carcinogenesis 34: 1413-19. https://doi.org/10.1093/carcin/bgt166
116. Shanin NP, Borodulin MM, Kolbovsky YuYa, Krasovsky VN (1983) Proizvodstvo asbestovyh tehnicheskih izdelii [Production of asbestos technical products]. Leningrad, Khimia. (in Russian)
117. Shtol AV, Plotko EG, Seliankina KP (2000) Zagrjaznenie atmosfernogo vozduha asbestosoderzhashhej pyl'ju i zdorov'e detskogo naselenija [Children's health and environmental air pollution with dust containing asbestos]. Meditsina Truda i Promyshlennaia Ekologiia [Russian journal of occupational health and industrial ecology] (11): 10-3. PMID: 11280276
118. Smith AH, Wright CC (1996) Chrysotile asbestos is the main cause of pleural mesothelioma. American Journal of Industrial Medicine 30: 252-66. https://doi.org/10.1002/(SICI)1097-0274(199609)30:3<252::AID-AJIM2>3.0.CO;2-0
119. Stayner LT (2008) Canada, chrysotile and cancer: Health Canada's Asbestos International Expert Panel report. Journal of Occupational and Environmental Medicine 50(12): 1327-8. https://doi.org/10.1097/JOM.0b013e318190eff3
120. Stayner LT, Dankovic DA, Lemen RA (1996) Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. American Journal of Public Health 86: 179-86. https://doi.org/10.2105/ajph.86.2.179
121. Stayner LT, Dankovic DA, Lemen RA (1997) Asbestos-related cancer and the amphibole hypothesis: 2. Stayner and colleagues respond. American Journal of Public Health 87: 688.
122. Suzuki Y, Yuen SR (2002) Asbestos fibers contributing to the induction of human malignant mesothelioma. Annals of the New York Academy of Sciences 982: 160-76. https://doi.org/10.1111/j.1749-6632.2002.tb04931.x.24
123. Suzuki Y, Yuen SR, Ashley R (2005) Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. International Journal of Hygiene and Environmental Health 208(3): 201-10. https://doi.org/10.1016/j.ijheh.2005.01.015
124. Testa JR, Carbone M, Hirvonen A, Khalili K, Krynska B, Linnainmaa K, Pooley FD, Rizzo P, Rusch V, Xiao GH (1998) A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Research 58(20): 4505-9. PMID: 9788590
125. Tomasetti M, Amati M, Santarelli L, Alleva R, Neuzil J (2009) Malignant mesothelioma: biology, diagnosis and therapeutic approaches. Current Molecular Pharmacology 2: 190-206. https://doi.org/10.2174/1874467210902020190
126. Tossavainen A, Kotilainen M, Takahashi K, Pan G, Vanhala E (2001) Amphibole fibres in Chinese chrysotile asbestos. Annals of Occupational Hygiene 45: 145-52. PMID: 11182428
127. Toyokuni S (2013) Genotoxicity and carcinogenicity risk of carbon nanotubes. Advanced Drug Delivery Reviews 65: 2098-110. https://doi.org/10.1016/j.addr.2013.05.011
128. Troitskaia NA (1993) Sravnitelʹnoye issledovaniye tsitotoksichnosti pyli uglerodnykh volokon i drugikh voloknistykh materialov [A comparative study of cytotoxicity of dust of carbon fibers and other fibrous materials]. Gigiena i Sanitariia [Hygiene and sanitation] (3): 28-30. PMID: 8063120
129. Tsurikova GV, Spitsyn VA, Gladkova EV, Minaeva OP (1992) Biodemograficheskiye parametry kak indikatory geneticheskoy adaptatsii k vrednym professionalʹnym faktoram na primere asbesta [Biodemographic parameters as indicators of genetic adaptation to harmful occupational factors (e.g. asbestos)]. Gigiena Truda i Professional’nye Zabolevaniia [Work hygiene and professional diseases] (6): 28-30. PMID: 1478521
130. Van Berlo D, Clift MJ, Albrecht C, Schins RP (2012) Carbon nanotubes: an insight into the mechanisms of their potential genotoxicity. Swiss Medical Weekly 142: w13698. https://doi.org/10.4414/smw.2012.13698
131. Vandenhoeck J, van Meerbeeck JP, Fransen E, Raskin J, Van Camp G, Op de Beeck K, Lamote K (2021) DNA methylation as a diagnostic biomarker for malignant mesothelioma: a systematic review and meta-analysis. Journal of Thoracic Oncology 16(9): 1461-78. https://doi.org/10.1016/j.jtho.2021.05.015
132. Vereshchagin A.L., Morozova E.A. Specific toxicity of nanoparticles (review). South-Siberian Scientific Bulletin 2022;1(41):76-88.
133. Voytsekhovskiy VV, Goborov ND, Landyshev YuS, Grigorenko AA, Lazutkina EL (2016) Features of diagnosis of malignant pleural mesothelioma. Byulleten' fiziologii i patologii dykhaniya [Bulletin physiology and pathology of respiration] (60): 85-93. https://doi.org/10.12737/20127
134. Wagner JC (1975) Proceedings: Asbestos carcinogenesis. British Journal of Cancer 32: 258-9. https://doi.org/10.1038/bjc.1975.206
135. Wagner JC, Berry G, Skidmore JW, Timbrell V (1974) The effects of the inhalation of asbestos in rats. British Journal of Cancer 29: 252-69. https://doi.org/10.1038/bjc.1974.65
136. Wang J, Schlagenhauf L, Setyan A (2017) Transformation of the released asbestos, carbon fibers and carbon nanotubes from composite materials and the changes of their potential health impacts. Journal of Nanobiotechnology 15(1): 15. https://doi.org/10.1186/s12951-017-0248-7
137. Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H (2015) Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations. Scandinavian Journal of Work and Environmental Health 41(1): 5-15. https://doi.org/10.5271/sjweh.3462
138. Wong JYY, Rice C, Blair A, Silverman DT (2020) Mesothelioma risk among those exposed to chrysotile asbestos only and mixtures that include amphibole: a case-control study in the USA, 1975-1980. Occupational and Environmental Medicine https://doi.org/10.1136/oemed-2020-106665
139. Yang H, Testa JR, Carbone M (2008) Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Current Treatment Options in Oncology 9: 147-57. https://doi.org/10.1007/s11864-008-0067-z
140. Yu CP, Asgharian B, Pinkerton KE (1991) Intrapulmonary deposition and retention modeling of chrysotile asbestos fibers in rats. Journal of Aerosol Science 22: 757-63. https://doi.org/10.1016/0021-8502(91)90068-S
